A 7-year-old boy from rural Bihar presents with progressive bowing of legs, delayed motor milestones, and dental enamel hypoplasia. Biochemistry shows serum calcium 7.2 mg/dL, phosphate 3.1 mg/dL, alkaline phosphatase 680 IU/L, and 25-hydroxyvitamin D 12 ng/mL. X-ray confirms metaphyseal widening and loss of sharp metaphyseal margins. What is the most appropriate immediate next step in management?

Explanation

## Clinical Context This child presents with **nutritional rickets** — the most common form in India. The biochemical triad is pathognomonic: - Low 25-hydroxyvitamin D (12 ng/mL; normal >30 ng/mL) - Hypocalcaemia (7.2 mg/dL) - Elevated alkaline phosphatase (bone turnover marker) - Elevated PTH (secondary hyperparathyroidism) The radiological findings (metaphyseal widening, loss of sharp margins) confirm active rickets. ## Management Algorithm for Nutritional Rickets ```mermaid flowchart TD A[Confirmed Nutritional Rickets]:::outcome --> B{Serum calcium level?}:::decision B -->|Normal or mild ↓| C[Oral Vitamin D2 600,000 IU weekly × 6 weeks]:::action B -->|Severe ↓ + tetany risk| D[IV Calcium gluconate + Vitamin D]:::urgent C --> E[Maintenance: 400-600 IU daily]:::action D --> F[After stabilization: Oral Vitamin D]:::action E --> G[Dietary counselling + sun exposure]:::action F --> G G --> H[Radiological healing in 4-6 weeks]:::outcome ``` ## Why Cholecalciferol (Vitamin D2) is First-Line **Key Point:** In **nutritional rickets with mild-to-moderate hypocalcaemia (>6.5 mg/dL) and no acute tetany**, oral vitamin D2 (ergocalciferol) is the standard initial therapy. | Feature | Vitamin D2 (Cholecalciferol) | Calcitriol (1,25-D3) | |---------|-----|-----| | **Onset** | 2–4 weeks | 24–48 hours | | **Indication** | Nutritional rickets (first-line) | Renal rickets, hypoparathyroidism, severe symptomatic hypocalcaemia | | **Dose** | 600,000 IU weekly × 6 weeks | 0.05 µg/kg/day (requires close monitoring) | | **Cost** | Very low (India) | Higher | | **Monitoring** | Less frequent | Frequent (risk of hypercalcaemia) | **High-Yield:** The standard protocol in India (WHO, ICMR guidelines) is **weekly mega-dose vitamin D2** for 6 weeks, followed by maintenance (400–600 IU daily) + dietary calcium + sun exposure. ## Why This Child Does NOT Need Calcitriol Immediately **Clinical Pearl:** Calcitriol is reserved for: - Renal rickets (low 1,25-D3 production) - Hypoparathyroidism (impaired PTH response) - **Acute severe symptomatic hypocalcaemia with tetany** (this child's calcium is 7.2, borderline but no mention of seizures/tetany) In nutritional rickets, the kidneys are intact and can convert 25-D to 1,25-D once substrate (25-D) is replenished. Calcitriol would be overkill and risks hypercalcaemia. ## Why Differentiation Tests Are Premature **Warning:** 1,25-D and PTH assays are useful for **atypical presentations** (e.g., hypophosphataemic rickets, vitamin D-dependent rickets type 1 or 2). This is classic **nutritional rickets** — the diagnosis is already clear from low 25-D and clinical picture. Testing delays therapy unnecessarily. ## Why IV Calcium Is Not First-Line Here **Tip:** IV calcium is reserved for **acute symptomatic hypocalcaemia** (seizures, tetany, QT prolongation on ECG). A calcium of 7.2 mg/dL in a child with no acute symptoms warrants oral vitamin D, not emergency IV therapy.